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A B S T R A C T
The aim of the study was to investigate the effects of continuous epidural analgesia (EA) on the course of vaginal de-
livery with an emphasis on duration of labor and instrumental interventions. In a prospective 2-year trial, the study
group included singleton vaginal births between 35 and 41 gestational weeks with a vertex fetus, in which continuous EA
with bupivacaine or chirocaine in concentration of 0.125% combined with 2–4 mg of fentanyl or 0.5 mg of sufenta was
used. The control group was created randomly from laboring patients with singleton pregnancies but without EA. The
groups were adjusted for epidemiological characteristics and compared regarding the obstetric data and perinatal out-
come. Student t-test and Mann-Whitney U-test were performed for normally and non-normally distributed results, re-
spectively. Out of 1284 patients, 551 pregnant women were included in the study group and 733 in the control group. The
statistically significant differences between the groups related to duration of the first and second stage of labor, frequency
of premature rupture of membranes, intrapartal complications, and incidence of operative deliveries were found. Both
stages of labor were significantly protracted and the incidence of operative deliveries was higher in the study group of pa-
tients compared with controls. There is a need for an active obstetric approach and management of vaginal deliveries of
women who receive continuous EA, particularly if it is medically indicated.
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Introduction
Epidural analgesia (EA) was introduced into obstetric
practice with the aim of eliminating or reducing visceral
pain from uterine contractions and cervical dilatation in
the first stage of labor and somatic pain from distension
and tearing of the perineal tissues during the second
stage of labor1,2. Analgesic effect of this invasive proce-
dure facilitates cervical dilatation and commonly acceler-
ates course of delivery in medically indicated cases. Since
its introduction, continuous EA at woman’s request has
become widely used in many delivery rooms worldwi-
de3–6. Although labor pain has been recognized as a cause
of increase in medical interventions, a number of reports
on higher incidence of operative deliveries associated
with EA have been found in the literature1,7–10. This clin-
ical observation could possibly diminish all advantages
and popularity of this helpful method for pain relief. On
the other hand, there are several studies with opposite
results and conclusions that addressed adverse effects of
EA on mode of delivery11,12. Therefore, additional re-
search is recommended4.
The aim of this clinical study was to investigate unfa-
vorable impacts of EA on vaginal delivery with an em-
phasis on its instrumental ending. We also want to sug-
gest, if proven necessary, measure(s) for effective preven-
tion or significant reduction of unnecessary operative in-
terventions during deliveries in which continuous EA is
used.
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Materials and Methods
Our prospective cohort study encompassed 1284 preg-
nant patients that have given birth at our Department of
Perinatology in two-year period from 2009 to 2010. Data
was collected from a database, medical records, and birth
protocols.
The study group included only singleton pregnancies
with fetus in vertex presentation, between 35 and 41
weeks of gestation, with an attempt of vaginal delivery,
in which continuous EA with bupivacaine or chirocaine
in concentration of 0.125% combined with 2–4 mg of
fentanyl or 0.5 mg of sufenta per milliliter of epidural in-
fusion according to patient’s height has been used. After
placement of epidural catheter, the infusion was started
at 8–12 mL per hour. Cases of stillbirths were excluded.
Gestational age was calculated by information on last
menstrual period and/or an early ultrasound examina-
tion prior to 22 weeks’ gestation. The control group was
created randomly from pregnant patients with singleton
pregnancies who also underwent vaginal delivery but
neither with EA nor with parenteral opioids. Both gro-
ups of patients were adjusted regarding their epidemio-
logical characteristics which included maternal age, par-
ity, height, weight and BMI before pregnancy. Written
informed consent was obtained from each participant of
the study group before onset of EA. This study was ap-
proved by Ethical Committee of the University Hospital
Center. All deliveries in both the study and the control
group were stimulated by oxytocin. The following obstet-
ric parameters for each pregnancy group were consid-
ered and compared: gestational age, onset of labor (regu-
lar contractions with 10 minute intervals; premature
rupture of membranes), duration of the first and the sec-
ond stage of labor, indications for EA, intrapartal compli-
cations (pathologic cardiotocographic patterns, fetal blood
pH<7.20, bradycardia), operative deliveries, and perina-
tal outcome (birth weight, 5-minute Apgar score; puer-
peral and neonatal morbidities). Intrapartal fetal blood
pH was determined only in cases of suspicious fetal com-
promise indicated by pathologic cardiotocographic pat-
terns and fetal bradycardia. Indications for EA were di-
vided into medical (rigid or spastic cervix with cervical
dilatation of 3 to 5 centimeters, previous cesarean, preec-
lampsia, etc.) and nonmedical ones that were based only
on woman’s request for pain relief.
Methods
Statistics
Statistical Package Statistica version 7.1 was used for
data analysis. To evaluate means, standard deviations,
medians, and other statistical parameters, descriptive
statistics were calculated. Data are presented in tables.
In comparative analyses Student t-test was performed
for normally distributed results and non-parametric te-
sts were done for non-normally distributed scale data
(Mann-Whitney U-test). Pearson’s correlation coefficient
was also used. A quantification of non-numeric data (cat-
egories) inside the observed group was expressed by pro-
portion or percentage, and the analysis was performed by
using c2-test. Statistical significance was considered at
p<0.05 with 95% confidence interval.
Results
Out of total number of patients, 551 pregnant women
were included in the study group and 733 in the control
group. The epidemiological characteristics of the study
and the control pregnant populations are presented in
Table 1 showing no statistical differences between the
groups (c2=5.24, p>0.05). The mean gestational ages
were 39.7 weeks and 39.4 weeks, respectively.
The incidence of maternal hypotension during labor
did not differ significantly between the EA and control
groups of patients. The main differences between the
epidural group and controls existed in obstetric charac-
teristics, particularly in duration of labor, frequency of
premature rupture of membranes (PROM), intrapartal
complications and incidence of operative deliveries. Fetal
distress (50%) and dystocia (40.8%) were the most fre-
quent indications for cesarean deliveries. Among patho-
logic conditions the incidences of previous cesarean (3.8%:
2.2%, c2=2.43, p=0.119) and preeclampsia (2%:1.6%,
c2=0.07, p=0.789) were not higher, but the incidence of
gestational diabetes / macrosomia (4%:1.5%, c2=6.84,
p<0.009) was significantly higher in the EA group than
in the control group. Detailed results are displayed in Ta-
ble 2. Fever was more frequent and the systemic antibiot-
ics and analgesics were more frequently administered in
puerperal women in the study group. Regarding neona-
tal outcomes there was no statistically significant differ-
ence in birth weight, neonatal asphyxia was more fre-
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TABLE 1
EPIDEMIOLOGICAL CHARACTERISTICS OF THE STUDY AND THE CONTROL GROUPS OF PATIENTS (n=1284)
Epidemiological characteristics Study group (N=551) Control group (N=733) p
Maternal age [X±SD] 29.0±5.0 29.0±4.7 0.561
Primiparous (%) 79.5 76.1 0.147
Height (cm) [X±SD] 167.9±6.1 168.4±6.1 0.126
Weight (kg) [X±SD] 79.9±11.0 80.6±11.9 0.712
BMI [X±SD] 28.3±3.6 28.4±3.8 0.941
N – number of cases, X±SD – mean ± standard deviation, BMI – body mass index, p – statistical significance (p<0.05)
quent in the study group than in controls, while the
percentage of infections was significantly higher in the
control group of neonates.
After deliveries with EA were divided according to in-
dications into subgroups of medical indications (Group 1)
and at woman’s request (Group 2), there were statisti-
cally significant differences in the duration of the first
stage of labor, as well as in incidence of operative delive-
ries between the compared subgroups of patients (c2=
13.33, p<0.001) (Table 3). On the other hand, no statisti-
cally significant differences in vacuum extractions (1.5%:
1.1%, c2=0.02, p=0.899) and cesarean deliveries (7.7%:
4.4%, c2=2.37, p=0.123) between the Group 2 and the
controls were found.
Discussion and Conclusion
Wide use of continuous EA is present in many coun-
tries of the world, in some of them in more than 50% of
yearly deliveries1,3,13–15. During the last five years the in-
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TABLE 2
OBSTETRIC CHARACTERISTICS AND NEONATAL OUTCOME IN THE STUDY AND THE CONTROL GROUP OF PATIENTS (n = 1284)
Obstetric characteristics Study group (N=551) Control group (N=733) p
Previous cesarean N(%) 21 (3.8) 16 (2.2) 0.119
GDM/macrosomia N(%) 22 (4.0) 11 (1.5) 0.009
Preeclampsia N(%) 11 (2.0) 12 (1.6) 0.789









Maternal hypotension 1 (0.2) 0 (0) 0.885
Pathologic cardiotocography 86 (15.8) 28 (3.8) <0.001
Fetal blood pH7.19 N(%) 32 (5.8) 12 (1.6) 0.516
First stage of labor (minutes) [median (range)] 480 (95–1020) 315 (95–845) <0.001
Second stage of labor (minutes) [median (range)] 45 (10–210) 30 (6–160) <0.001
Vaginal delivery N(%) 456 (82.8) 692 (94.5) <0.001
Vacuum extraction N(%) 19 (3.5) 8 (1.1) 0.007
Cesarean section N(%) 76 (13.8) 32 (4.4) <0.001
Puerperium N(%):
– fever >38°C
– use of analgesics















Birth weight (grams) [X±SD] 3477±464 3452±464 0.334
API 5’<7 N(%) 4 (0.7) 1 (0.1) 0.093
Neonatal infection N(%) 12 (2.3) 49 (6.7) 0.001
Neonatal asphyxia N(%) 6 (1.1) 0 (0) 0.015
N(%) – number of cases (percentage), X±SD – mean ± standard deviation, PROM – premature rupture of membranes, p – statistical
significance (p<0.05)
TABLE 3
OBSTETRIC CHARACTERISTICS OF DELIVERIES WITH EPIDURAL ANALGESIA ACCORDING TO INDICATIONS (»MEDICAL« – GROUP 1
AND »AT WOMAN’S REQUEST« – GROUP 2)
Obstetric characteristics Group 1 (N=355) Group 2 (N=196) p
First stage of labor (minutes) [median (range)] 514.8 (120-1020) 420 (95–910) <0.001
Second stage of labor (minutes) [median (range)] 50 (18-210) 40 (10–170) 0.102
Vaginal delivery N(%) 278 (78.3) 178 (90.8) <0.001
Vacuum extraction N(%) 15 (4.5) 3 (1.5) 0.001
Cesarean section N(%) 61 (17.2) 15 (7.7) <0.001
N(%) – number of cases (percentage), p – statistical significance (c2=13.33, p<0.001)
cidence of EA at our Department exceeded 20%. This in-
vasive method of labor pain suppression deserves obste-
trician’s attention, because there is higher responsibility
for obstetrician if labor is influenced by use of EA. De-
spite many favorable effects of EA, an increased number
of instrumental deliveries has been noted5,10,16.
We hypothesized that a classic expectant approach to
vaginal delivery with EA, and particularly its second
stage, is mostly responsible for prolongation of labor and
an increased number of obstetric interventions at the
end of labor. To support this claim we decided to conduct
this prospective clinical study with strictly defined study
and control group of pregnancies that were adjusted for
their epidemiological characteristics. Namely, our inten-
tion was to minimize or even eliminate potential influ-
ences of these confounding factors.
Our research confirmed that deliveries with EA were
accompanied by a higher incidence of vacuum-extrac-
tions and cesarean sections, which is in agreement with
conclusions of Anim-Somuah and coworkers who re-
ported increased risks of instrumental vaginal birth and
cesarean section due to acute fetal distress in the epi-
dural group of patients17. According to indications for op-
erative deliveries, the most frequent ones were acute fe-
tal distress (bradycardia, acidosis), dystocia (abnormali-
ties of cervical dilatation, presentation or rotation) and
absence of the fetal head descent due to inadequate pre-
dominantly decreased uterine contractions as a conse-
quence of protracted labor. Fetal acidosis was detected
3.6 times more frequently in the EA group of deliveries
than in control cases but statistical difference was not
found. In addition, it is possible that higher frequency of
some pathologic conditions (PROM, GDM/macrosomia)
in this group of pregnancies also contributes to higher
risk of operative deliveries in the EA group. Although EA
was discontinuated in these obstetric cases, analysis sho-
wed that it was done only in the late phase of second
stage of labor or even later, after two hours of its dura-
tion. Therefore, this medical action could not have any
favorable impact on obstetric outcome.
Our hypothesis has been proven by the most obvious
study result which was a significantly prolonged dura-
tion of both the first and the second stage of labor, partic-
ularly when EA was installed for medical reasons. The
same experiences were reported by others1,11. Time rela-
tionship between the first and the second stage of labor
(480 min : 45min) remained the same in the EA group of
participants (ratio 10.6) as it was in controls (315min :
30min, ratio 10.5), which means that both stages of labor
were proportionally influenced by EA. It is well known
that EA reduces labor pain but also removes neuro-
muscular reflex mechanism that commonly increases
uterine expulsion forces, simultaneously with strong ute-
rine contractions, by activating maternal abdominal wall
muscles. By abandoning this important physiological re-
flex at the late phase of labor, EA becomes an inhibiting
factor of a natural and otherwise self-limited birthing
process18,19. That is why we consider the approach and
management of vaginal delivery that are used for deliver-
ies without EA as inefficient and insufficiently safe for
deliveries with EA. Expectant management of deliveries
with EA, without additional engagement of the physician
most frequently leads to prolongation of the vaginal de-
livery without any clinical justification. Therefore, chan-
ces for intrapartal complications like fetal compromise
and secondary uterine inertia as well as some puerperal
morbidities and neonatal asphyxia are increased in such
cases. This study showed a higher incidence of fever and
a significantly increased administration of analgesics
and antibiotics in puerperal period, but we found no dif-
ferences in incidence of urine retention between the EA
and the control group, as it was reported in studies of
other authors20.
When considering deliveries with medical indication
for EA, several medical measures and procedures could
be recommended with the aim of preventing specific
intrapartum complications and reducing a number of un-
necessary operative obstetric interventions. Most impor-
tant is to always keep in mind the laboring woman who is
receiving EA in the delivery room. Obstetricians should
do their best to explain and inform the pregnant women
before the procedure about risks and possibly higher in-
cidence of some complications in relation to vaginal de-
liveries without EA (prolonged labor, intrapartal, puer-
peral and neonatal complications), which was clearly
assigned in this clinical study. Written informed consent
should be obligatory before the procedure of epidural
insertion6. Secondly, the obstetrician should be aware of
cases with PROM and primary uterine inertia, when he
or she decides about EA. Controlled oxytocin augmenta-
tion must be used in all deliveries with EA. Our prelimi-
nary but till now unpublished findings suggest that an
active approach to cervical dilatation by a careful and
gentle digital massage of the cervical tissue during uter-
ine contractions, particularly in cases that started with
PROM should be preferred. The correctness of these rec-
ommendations is substantiated by cases of delivery with
non-medical indication for EA, with no problems about
cervical ostium and in which the first phase of labor is
significantly shorter than in deliveries with EA where
that is medically indicated. For now, we can only specu-
late that the next step should be stopping the continuous
EA at the right moment, at cervical dilation of 7–8 cm,
particularly if uterine contractions are insufficient de-
spite adequate drug stimulation and/or there is no com-
pression of fetal head on cervical ostium. This opinion is
based on a logical premise that the discontinuation of EA
can reactivate the previously inactivated reflex mecha-
nism in approximately 20–40 minutes allowing labor to
progress and to reduce labor delays and incidence of op-
erative deliveries. A similar idea has been already pro-
posed, but definitive conclusions are inconsistent1,4,21.
Some authors have suggested more appropriate combi-
nations of drugs or even some new and more appropriate
epidural procedures in order to reduce the incidence of
operative deliveries, particularly cesareans but also some
other adverse impacts of EA17,22,23.
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It seems that catastrophizing significantly influences
the pregnant woman’s request for pain relief24. Our in-
vestigation showed no reason to quit with usage of con-
tinuous EA on woman’s wish, because the rates of opera-
tive deliveries did not differ between this epidural sub-
group of patients and controls. In these cases EA could be
used even in early phases of labor without unfavorable
consequences to duration and mode of delivery25.
In conclusion, the obtained study results, based on
analyses of strictly defined study and control group of
pregnancies that were adjusted for their epidemiological
characteristics, confirmed that deliveries with EA were
associated with a higher incidence of vacuum-extractions
and cesareans, most probably due to a significantly pro-
longed duration of both the first and the second stage of
labor, particularly when EA was installed for medical
reasons. A higher frequency of some pathologic condi-
tions could also contribute to higher risk of operative de-
liveries in the EA group. Therefore, there certainly is a
need for an active medical engagement but each obstetri-
cian’s decision on use of EA should also be individualized
according to specific circumstances of the obstetric case.
In that way, adverse effects of EA and unnecessary oper-
ative deliveries could be avoided more accurately, which
is an important prerequisite for improving overall pa-
tient’s satisfaction.
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VAGINALNI POROD I KONTINUIRANA EPIDURALNA ANALGEZIJA: TREBAMO LI MIJENJATI
NA[ KLINI^KI PRISTUP?
S A @ E T A K
Cilj studije bio je istra`iti u~inke kontinuirane epiduralne analgezije (EA) na tijek vaginalnog poroda s posebnim
naglaskom na trajanje poroda i operacijske intervencije. U dvogodi{njem prospektivnom istra`ivanju ispitivanu skupi-
nu sa~injavali su jednoplodni vaginalni porodi u stavu glavicom, izme|u 35. i 41. tjedna trudno}e, kod kojih je primije-
njena kontinuirana EA s bupivakainom ili hirokainom u koncentraciji od 0,125 % u kombinaciji s 2–4 mg fentanila ili 0,5
mg sufente. Kontrolna skupina formirana je slu~ajnim odabirom tako|er jednoplodnih poroda u kojih nije primijenjena
EA. Skupine su »izjedna~ene« prema epidemiolo{kim karakteristikama, a uspore|ene glede tijeka poroda (opsteri~ki
parametri) i perinatalnog ishoda. Za statisti~ku analizu rezultata kori{teni su Student t-test za normalnu raspodjelu, a
Mann-Whitney U test za rezultate koji nemaju normalnu raspodjelu. Od ukupno 1284 rodilje, u ispitivanoj skupini bila
je 551, a u kontrolnoj skupini 733 rodilje. Izme|u dviju skupina ustanovljene su statisti~ki znakovite razlike s obzirom
na trajanje prvog i drugog porodnog doba, u~estalost prijevremenog prsnu}a plodovih ovojnica, broj intrapartalnih
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komplikacija i operacijsko dovr{enje poroda. U ispitivanoj skupini poroda utvr|eno je statisti~ki znakovito du`e trajanje
prvog i drugog porodnog doba i ve}a u~estalost operacijski dovr{enih poroda u usporedbi s kontrolnom skupinom. Auto-
ri zaklju~uju da je potreban aktivan opstetri~ki pristup i vo|enje vaginalnih poroda kod `ena koje ra|aju uz kontinui-
ranu EA, posebice ako se EA primjenjuje zbog medicinskih indikacija.
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